The global Tuberculosis Diagnostics Testing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.

Tuberculosis diagnostic testing is the process of detecting Mycobacterium tuberculosis infection and evaluating disease status through a range of methods, such as skin tests, sputum sample analysis, imaging and blood tests, and molecular biology techniques. These tests help to confirm the presence and type of TB.

From a downstream perspective, Medical Diagnosis accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Tuberculosis Diagnostics Testing leading manufacturers including Abbott Laboratories, Becton, Dickinson and Company (BD), BioMerieux SA, Cepheid (Danaher Corporation), Hologic, Inc., Hain Lifescience GmbH, Oxford Immunotec (PerkinElmer), Qiagen N.V., Roche Molecular Systems Inc., Siemens Healthineers AG, etc., dominate supply; the top five capture approximately % of global revenue, with Abbott Laboratories leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Tuberculosis Diagnostics Testing market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Tuberculosis Diagnostics Testing Market Report

Report Metric	Details
Report Name	Tuberculosis Diagnostics Testing Market
Segment by Type	Diagnostic Laboratory Molecular Diagnostics Cytokine Detection Assay Others
Segment by Application	Medical Diagnosis Epidemiologic Investigations Public Health Control Others
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories, Becton, Dickinson and Company (BD), BioMerieux SA, Cepheid (Danaher Corporation), Hologic, Inc., Hain Lifescience GmbH, Oxford Immunotec (PerkinElmer), Qiagen N.V., Roche Molecular Systems Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Tuberculosis Diagnostics Testing study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Tuberculosis Diagnostics Testing Market report?

Ans: The main players in the Tuberculosis Diagnostics Testing Market are Abbott Laboratories, Becton, Dickinson and Company (BD), BioMerieux SA, Cepheid (Danaher Corporation), Hologic, Inc., Hain Lifescience GmbH, Oxford Immunotec (PerkinElmer), Qiagen N.V., Roche Molecular Systems Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc.

What are the Application segmentation covered in the Tuberculosis Diagnostics Testing Market report?

Ans: The Applications covered in the Tuberculosis Diagnostics Testing Market report are Medical Diagnosis, Epidemiologic Investigations, Public Health Control, Others

What are the Type segmentation covered in the Tuberculosis Diagnostics Testing Market report?

Ans: The Types covered in the Tuberculosis Diagnostics Testing Market report are Diagnostic Laboratory, Molecular Diagnostics, Cytokine Detection Assay, Others

1 Study Coverage

1.1 Introduction to Tuberculosis Diagnostics Testing: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Tuberculosis Diagnostics Testing Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Diagnostic Laboratory

1.2.3 Molecular Diagnostics

1.2.4 Cytokine Detection Assay

1.2.5 Others

1.3 Market Segmentation by Application

1.3.1 Global Tuberculosis Diagnostics Testing Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Medical Diagnosis

1.3.3 Epidemiologic Investigations

1.3.4 Public Health Control

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Tuberculosis Diagnostics Testing Revenue Estimates and Forecasts 2020-2031

2.2 Global Tuberculosis Diagnostics Testing Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020-2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competition by Players

3.1 Global Tuberculosis Diagnostics Testing Player Revenue Rankings and Profitability

3.1.1 Global Revenue (Value) by Players (2020-2025)

3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)

3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.1.4 Gross Margin by Top Player (2020 VS 2024)

3.2 Global Tuberculosis Diagnostics Testing Companies Headquarters and Service Footprint

3.3 Main Product Type Market Size by Players

3.3.1 Diagnostic Laboratory Market Size by Players

3.3.2 Molecular Diagnostics Market Size by Players

3.3.3 Cytokine Detection Assay Market Size by Players

3.3.4 Others Market Size by Players

3.4 Global Tuberculosis Diagnostics Testing Market Concentration and Dynamics

3.4.1 Global Market Concentration (CR5 and HHI)

3.4.2 Entrant/Exit Impact Analysis

3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Tuberculosis Diagnostics Testing Revenue Trends by Type

4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.1.2 Global Revenue Market Share by Type (2020-2031)

4.2 Key Product Attributes and Differentiation

4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.3.1 High-Growth Niches and Adoption Drivers

4.3.2 Profitability Hotspots and Cost Drivers

4.3.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Tuberculosis Diagnostics Testing Revenue by Application

5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.1.2 Revenue Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Downstream Customer Analysis

5.2.1 Top Customers by Region

5.2.2 Top Customers by Application

6 North America

6.1 North America Market Size (2020-2031)

6.2 North America Key Players Revenue in 2024

6.3 North America Tuberculosis Diagnostics Testing Market Size by Type (2020-2031)

6.4 North America Tuberculosis Diagnostics Testing Market Size by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Tuberculosis Diagnostics Testing Market Size by Country

6.6.1 North America Revenue Trends by Country

6.6.2 US

6.6.3 Canada

6.6.4 Mexico

7 Europe

7.1 Europe Market Size (2020-2031)

7.2 Europe Key Players Revenue in 2024

7.3 Europe Tuberculosis Diagnostics Testing Market Size by Type (2020-2031)

7.4 Europe Tuberculosis Diagnostics Testing Market Size by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Tuberculosis Diagnostics Testing Market Size by Country

7.6.1 Europe Revenue Trends by Country

7.6.2 Germany

7.6.3 France

7.6.4 U.K.

7.6.5 Italy

7.6.6 Russia

8 Asia-Pacific

8.1 Asia-Pacific Market Size (2020-2031)

8.2 Asia-Pacific Key Players Revenue in 2024

8.3 Asia-Pacific Tuberculosis Diagnostics Testing Market Size by Type (2020-2031)

8.4 Asia-Pacific Tuberculosis Diagnostics Testing Market Size by Application (2020-2031)

8.5 Asia-Pacific Growth Accelerators and Market Barriers

8.6 Asia-Pacific Tuberculosis Diagnostics Testing Market Size by Region

8.6.1 Asia-Pacific Revenue Trends by Region

8.7 China

8.8 Japan

8.9 South Korea

8.10 Australia

8.11 India

8.12 Southeast Asia

8.12.1 Indonesia

8.12.2 Vietnam

8.12.3 Malaysia

8.12.4 Philippines

8.12.5 Singapore

9 Central and South America

9.1 Central and South America Market Size (2020-2031)

9.2 Central and South America Key Players Revenue in 2024

9.3 Central and South America Tuberculosis Diagnostics Testing Market Size by Type (2020-2031)

9.4 Central and South America Tuberculosis Diagnostics Testing Market Size by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Tuberculosis Diagnostics Testing Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Market Size (2020-2031)

10.2 Middle East and Africa Key Players Revenue in 2024

10.3 Middle East and Africa Tuberculosis Diagnostics Testing Market Size by Type (2020-2031)

10.4 Middle East and Africa Tuberculosis Diagnostics Testing Market Size by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Tuberculosis Diagnostics Testing Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Israel

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Corporation Information

11.1.2 Abbott Laboratories Business Overview

11.1.3 Abbott Laboratories Tuberculosis Diagnostics Testing Product Features and Attributes

11.1.4 Abbott Laboratories Tuberculosis Diagnostics Testing Revenue and Gross Margin (2020-2025)

11.1.5 Abbott Laboratories Tuberculosis Diagnostics Testing Revenue by Product in 2024

11.1.6 Abbott Laboratories Tuberculosis Diagnostics Testing Revenue by Application in 2024

11.1.7 Abbott Laboratories Tuberculosis Diagnostics Testing Revenue by Geographic Area in 2024

11.1.8 Abbott Laboratories Tuberculosis Diagnostics Testing SWOT Analysis

11.1.9 Abbott Laboratories Recent Developments

11.2 Becton, Dickinson and Company (BD)

11.2.1 Becton, Dickinson and Company (BD) Corporation Information

11.2.2 Becton, Dickinson and Company (BD) Business Overview

11.2.3 Becton, Dickinson and Company (BD) Tuberculosis Diagnostics Testing Product Features and Attributes

11.2.4 Becton, Dickinson and Company (BD) Tuberculosis Diagnostics Testing Revenue and Gross Margin (2020-2025)

11.2.5 Becton, Dickinson and Company (BD) Tuberculosis Diagnostics Testing Revenue by Product in 2024

11.2.6 Becton, Dickinson and Company (BD) Tuberculosis Diagnostics Testing Revenue by Application in 2024

11.2.7 Becton, Dickinson and Company (BD) Tuberculosis Diagnostics Testing Revenue by Geographic Area in 2024

11.2.8 Becton, Dickinson and Company (BD) Tuberculosis Diagnostics Testing SWOT Analysis

11.2.9 Becton, Dickinson and Company (BD) Recent Developments

11.3 BioMerieux SA

11.3.1 BioMerieux SA Corporation Information

11.3.2 BioMerieux SA Business Overview

11.3.3 BioMerieux SA Tuberculosis Diagnostics Testing Product Features and Attributes

11.3.4 BioMerieux SA Tuberculosis Diagnostics Testing Revenue and Gross Margin (2020-2025)

11.3.5 BioMerieux SA Tuberculosis Diagnostics Testing Revenue by Product in 2024

11.3.6 BioMerieux SA Tuberculosis Diagnostics Testing Revenue by Application in 2024

11.3.7 BioMerieux SA Tuberculosis Diagnostics Testing Revenue by Geographic Area in 2024

11.3.8 BioMerieux SA Tuberculosis Diagnostics Testing SWOT Analysis

11.3.9 BioMerieux SA Recent Developments

11.4 Cepheid (Danaher Corporation)

11.4.1 Cepheid (Danaher Corporation) Corporation Information

11.4.2 Cepheid (Danaher Corporation) Business Overview

11.4.3 Cepheid (Danaher Corporation) Tuberculosis Diagnostics Testing Product Features and Attributes

11.4.4 Cepheid (Danaher Corporation) Tuberculosis Diagnostics Testing Revenue and Gross Margin (2020-2025)

11.4.5 Cepheid (Danaher Corporation) Tuberculosis Diagnostics Testing Revenue by Product in 2024

11.4.6 Cepheid (Danaher Corporation) Tuberculosis Diagnostics Testing Revenue by Application in 2024

11.4.7 Cepheid (Danaher Corporation) Tuberculosis Diagnostics Testing Revenue by Geographic Area in 2024

11.4.8 Cepheid (Danaher Corporation) Tuberculosis Diagnostics Testing SWOT Analysis

11.4.9 Cepheid (Danaher Corporation) Recent Developments

11.5 Hologic, Inc.

11.5.1 Hologic, Inc. Corporation Information

11.5.2 Hologic, Inc. Business Overview

11.5.3 Hologic, Inc. Tuberculosis Diagnostics Testing Product Features and Attributes

11.5.4 Hologic, Inc. Tuberculosis Diagnostics Testing Revenue and Gross Margin (2020-2025)

11.5.5 Hologic, Inc. Tuberculosis Diagnostics Testing Revenue by Product in 2024

11.5.6 Hologic, Inc. Tuberculosis Diagnostics Testing Revenue by Application in 2024

11.5.7 Hologic, Inc. Tuberculosis Diagnostics Testing Revenue by Geographic Area in 2024

11.5.8 Hologic, Inc. Tuberculosis Diagnostics Testing SWOT Analysis

11.5.9 Hologic, Inc. Recent Developments

11.6 Hain Lifescience GmbH

11.6.1 Hain Lifescience GmbH Corporation Information

11.6.2 Hain Lifescience GmbH Business Overview

11.6.3 Hain Lifescience GmbH Tuberculosis Diagnostics Testing Product Features and Attributes

11.6.4 Hain Lifescience GmbH Tuberculosis Diagnostics Testing Revenue and Gross Margin (2020-2025)

11.6.5 Hain Lifescience GmbH Recent Developments

11.7 Oxford Immunotec (PerkinElmer)

11.7.1 Oxford Immunotec (PerkinElmer) Corporation Information

11.7.2 Oxford Immunotec (PerkinElmer) Business Overview

11.7.3 Oxford Immunotec (PerkinElmer) Tuberculosis Diagnostics Testing Product Features and Attributes

11.7.4 Oxford Immunotec (PerkinElmer) Tuberculosis Diagnostics Testing Revenue and Gross Margin (2020-2025)

11.7.5 Oxford Immunotec (PerkinElmer) Recent Developments

11.8 Qiagen N.V.

11.8.1 Qiagen N.V. Corporation Information

11.8.2 Qiagen N.V. Business Overview

11.8.3 Qiagen N.V. Tuberculosis Diagnostics Testing Product Features and Attributes

11.8.4 Qiagen N.V. Tuberculosis Diagnostics Testing Revenue and Gross Margin (2020-2025)

11.8.5 Qiagen N.V. Recent Developments

11.9 Roche Molecular Systems Inc.

11.9.1 Roche Molecular Systems Inc. Corporation Information

11.9.2 Roche Molecular Systems Inc. Business Overview

11.9.3 Roche Molecular Systems Inc. Tuberculosis Diagnostics Testing Product Features and Attributes

11.9.4 Roche Molecular Systems Inc. Tuberculosis Diagnostics Testing Revenue and Gross Margin (2020-2025)

11.9.5 Roche Molecular Systems Inc. Recent Developments

11.10 Siemens Healthineers AG

11.10.1 Siemens Healthineers AG Corporation Information

11.10.2 Siemens Healthineers AG Business Overview

11.10.3 Siemens Healthineers AG Tuberculosis Diagnostics Testing Product Features and Attributes

11.10.4 Siemens Healthineers AG Tuberculosis Diagnostics Testing Revenue and Gross Margin (2020-2025)

11.10.5 Company Ten Recent Developments

11.11 Thermo Fisher Scientific Inc.

11.11.1 Thermo Fisher Scientific Inc. Corporation Information

11.11.2 Thermo Fisher Scientific Inc. Business Overview

11.11.3 Thermo Fisher Scientific Inc. Tuberculosis Diagnostics Testing Product Features and Attributes

11.11.4 Thermo Fisher Scientific Inc. Tuberculosis Diagnostics Testing Revenue and Gross Margin (2020-2025)

11.11.5 Thermo Fisher Scientific Inc. Recent Developments

12 Tuberculosis Diagnostics TestingIndustry Chain Analysis

12.1 Tuberculosis Diagnostics Testing Industry Chain

12.2 Upstream Analysis

12.2.1 Upstream Key Suppliers

12.3 Middlestream Analysis

12.4 Downstream Sales Model and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Tuberculosis Diagnostics Testing Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Tuberculosis Diagnostics Testing Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Abbott Laboratories

Becton Dickinson and Company (BD)

BioMerieux SA

Cepheid(Danaher Corporation)

Hologic Inc

Hain Lifescience GmbH

QIAGEN N V

Roche Molecular Systems Inc.

Siemens Healthineers AG

Thermo Fisher Scientific Inc

Oxford Immunotec (PerkinElmer)

List of Tables

Table 1. Global Tuberculosis Diagnostics Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Tuberculosis Diagnostics Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Tuberculosis Diagnostics Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Tuberculosis Diagnostics Testing Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Tuberculosis Diagnostics Testing Revenue by Region (2026-2031) & (US$ Million)

Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 7. Global Tuberculosis Diagnostics Testing Revenue by Players (2020-2025) & (US$ Million)

Table 8. Global Tuberculosis Diagnostics Testing Revenue Market Share by Players (2020-2025)

Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 10. Global Tuberculosis Diagnostics Testing by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Diagnostics Testing as of 2024)

Table 11. Global Tuberculosis Diagnostics Testing Average Gross Margin (%) by Player (2020 VS 2024)

Table 12. Global Tuberculosis Diagnostics Testing Companies Headquarters

Table 13. Global Tuberculosis Diagnostics Testing Market Concentration Ratio (CR5 and HHI)

Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 16. Global Tuberculosis Diagnostics Testing Revenue by Type (2020-2025) & (US$ Million)

Table 17. Global Tuberculosis Diagnostics Testing Revenue by Type (2026-2031) & (US$ Million)

Table 18. Key Product Attributes and Differentiation

Table 19. Global Tuberculosis Diagnostics Testing Revenue by Application (2020-2025) & (US$ Million)

Table 20. Global Tuberculosis Diagnostics Testing Revenue by Application (2026-2031) & (US$ Million)

Table 21. Tuberculosis Diagnostics Testing High-Growth Sectors Demand CAGR (2024-2031)

Table 22. Top Customers by Region

Table 23. Top Customers by Application

Table 24. North America Tuberculosis Diagnostics Testing Growth Accelerators and Market Barriers

Table 25. North America Tuberculosis Diagnostics Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 26. Europe Tuberculosis Diagnostics Testing Growth Accelerators and Market Barriers

Table 27. Europe Tuberculosis Diagnostics Testing Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 28. Asia-Pacific Tuberculosis Diagnostics Testing Growth Accelerators and Market Barriers

Table 29. Asia-Pacific Tuberculosis Diagnostics Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 30. Central and South America Tuberculosis Diagnostics Testing Investment Opportunities and Key Challenges

Table 31. Central and South America Tuberculosis Diagnostics Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 32. Middle East and Africa Tuberculosis Diagnostics Testing Investment Opportunities and Key Challenges

Table 33. Middle East and Africa Tuberculosis Diagnostics Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 34. Abbott Laboratories Corporation Information

Table 35. Abbott Laboratories Description and Major Businesses

Table 36. Abbott Laboratories Product Features and Attributes

Table 37. Abbott Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)

Table 38. Abbott Laboratories Revenue Proportion by Product in 2024

Table 39. Abbott Laboratories Revenue Proportion by Application in 2024

Table 40. Abbott Laboratories Revenue Proportion by Geographic Area in 2024

Table 41. Abbott Laboratories Tuberculosis Diagnostics Testing SWOT Analysis

Table 42. Abbott Laboratories Recent Developments

Table 43. Becton, Dickinson and Company (BD) Corporation Information

Table 44. Becton, Dickinson and Company (BD) Description and Major Businesses

Table 45. Becton, Dickinson and Company (BD) Product Features and Attributes

Table 46. Becton, Dickinson and Company (BD) Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. Becton, Dickinson and Company (BD) Revenue Proportion by Product in 2024

Table 48. Becton, Dickinson and Company (BD) Revenue Proportion by Application in 2024

Table 49. Becton, Dickinson and Company (BD) Revenue Proportion by Geographic Area in 2024

Table 50. Becton, Dickinson and Company (BD) Tuberculosis Diagnostics Testing SWOT Analysis

Table 51. Becton, Dickinson and Company (BD) Recent Developments

Table 52. BioMerieux SA Corporation Information

Table 53. BioMerieux SA Description and Major Businesses

Table 54. BioMerieux SA Product Features and Attributes

Table 55. BioMerieux SA Revenue (US$ Million) and Gross Margin (2020-2025)

Table 56. BioMerieux SA Revenue Proportion by Product in 2024

Table 57. BioMerieux SA Revenue Proportion by Application in 2024

Table 58. BioMerieux SA Revenue Proportion by Geographic Area in 2024

Table 59. BioMerieux SA Tuberculosis Diagnostics Testing SWOT Analysis

Table 60. BioMerieux SA Recent Developments

Table 61. Cepheid (Danaher Corporation) Corporation Information

Table 62. Cepheid (Danaher Corporation) Description and Major Businesses

Table 63. Cepheid (Danaher Corporation) Product Features and Attributes

Table 64. Cepheid (Danaher Corporation) Revenue (US$ Million) and Gross Margin (2020-2025)

Table 65. Cepheid (Danaher Corporation) Revenue Proportion by Product in 2024

Table 66. Cepheid (Danaher Corporation) Revenue Proportion by Application in 2024

Table 67. Cepheid (Danaher Corporation) Revenue Proportion by Geographic Area in 2024

Table 68. Cepheid (Danaher Corporation) Tuberculosis Diagnostics Testing SWOT Analysis

Table 69. Cepheid (Danaher Corporation) Recent Developments

Table 70. Hologic, Inc. Corporation Information

Table 71. Hologic, Inc. Description and Major Businesses

Table 72. Hologic, Inc. Product Features and Attributes

Table 73. Hologic, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)

Table 74. Hologic, Inc. Revenue Proportion by Product in 2024

Table 75. Hologic, Inc. Revenue Proportion by Application in 2024

Table 76. Hologic, Inc. Revenue Proportion by Geographic Area in 2024

Table 77. Hologic, Inc. Tuberculosis Diagnostics Testing SWOT Analysis

Table 78. Hologic, Inc. Recent Developments

Table 79. Hain Lifescience GmbH Corporation Information

Table 80. Hain Lifescience GmbH Description and Major Businesses

Table 81. Hain Lifescience GmbH Product Features and Attributes

Table 82. Hain Lifescience GmbH Revenue (US$ Million) and Gross Margin (2020-2025)

Table 83. Hain Lifescience GmbH Recent Developments

Table 84. Oxford Immunotec (PerkinElmer) Corporation Information

Table 85. Oxford Immunotec (PerkinElmer) Description and Major Businesses

Table 86. Oxford Immunotec (PerkinElmer) Product Features and Attributes

Table 87. Oxford Immunotec (PerkinElmer) Revenue (US$ Million) and Gross Margin (2020-2025)

Table 88. Oxford Immunotec (PerkinElmer) Recent Developments

Table 89. Qiagen N.V. Corporation Information

Table 90. Qiagen N.V. Description and Major Businesses

Table 91. Qiagen N.V. Product Features and Attributes

Table 92. Qiagen N.V. Revenue (US$ Million) and Gross Margin (2020-2025)

Table 93. Qiagen N.V. Recent Developments

Table 94. Roche Molecular Systems Inc. Corporation Information

Table 95. Roche Molecular Systems Inc. Description and Major Businesses

Table 96. Roche Molecular Systems Inc. Product Features and Attributes

Table 97. Roche Molecular Systems Inc. Revenue (US$ Million) and Gross Margin (2020-2025)

Table 98. Roche Molecular Systems Inc. Recent Developments

Table 99. Siemens Healthineers AG Corporation Information

Table 100. Siemens Healthineers AG Description and Major Businesses

Table 101. Siemens Healthineers AG Product Features and Attributes

Table 102. Siemens Healthineers AG Revenue (US$ Million) and Gross Margin (2020-2025)

Table 103. Siemens Healthineers AG Recent Developments

Table 104. Thermo Fisher Scientific Inc. Corporation Information

Table 105. Thermo Fisher Scientific Inc. Description and Major Businesses

Table 106. Thermo Fisher Scientific Inc. Product Features and Attributes

Table 107. Thermo Fisher Scientific Inc. Revenue (US$ Million) and Gross Margin (2020-2025)

Table 108. Thermo Fisher Scientific Inc. Recent Developments

Table 109. Raw Materials Key Suppliers

Table 110. Distributors List

Table 111. Market Trends and Market Evolution

Table 112. Market Drivers and Opportunities

Table 113. Market Challenges, Risks, and Restraints

Table 114. Research Programs/Design for This Report

Table 115. Key Data Information from Secondary Sources

Table 116. Key Data Information from Primary Sources

List of Figures

Figure 1. Tuberculosis Diagnostics Testing Product Picture

Figure 2. Global Tuberculosis Diagnostics Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Diagnostic Laboratory Product Picture

Figure 4. Molecular Diagnostics Product Picture

Figure 5. Cytokine Detection Assay Product Picture

Figure 6. Others Product Picture

Figure 7. Global Tuberculosis Diagnostics Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 8. Medical Diagnosis

Figure 9. Epidemiologic Investigations

Figure 10. Public Health Control

Figure 11. Others

Figure 12. Tuberculosis Diagnostics Testing Report Years Considered

Figure 13. Global Tuberculosis Diagnostics Testing Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Tuberculosis Diagnostics Testing Revenue (2020-2031) & (US$ Million)

Figure 15. Global Tuberculosis Diagnostics Testing Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 16. Global Tuberculosis Diagnostics Testing Revenue Market Share by Region (2020-2031)

Figure 17. Global Tuberculosis Diagnostics Testing Revenue Market Share Ranking (2024)

Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 19. Diagnostic Laboratory Revenue Market Share by Player in 2024

Figure 20. Molecular Diagnostics Revenue Market Share by Player in 2024

Figure 21. Cytokine Detection Assay Revenue Market Share by Player in 2024

Figure 22. Others Revenue Market Share by Player in 2024

Figure 23. Global Tuberculosis Diagnostics Testing Revenue Market Share by Type (2020-2031)

Figure 24. Global Tuberculosis Diagnostics Testing Revenue Market Share by Application (2020-2031)

Figure 25. North America Tuberculosis Diagnostics Testing Revenue YoY (2020-2031) & (US$ Million)

Figure 26. North America Top 5 Players Tuberculosis Diagnostics Testing Revenue (US$ Million) in 2024

Figure 27. North America Tuberculosis Diagnostics Testing Revenue (US$ Million) by Type (2020 - 2031)

Figure 28. North America Tuberculosis Diagnostics Testing Revenue (US$ Million) by Application (2020-2031)

Figure 29. US Tuberculosis Diagnostics Testing Revenue (2020-2031) & (US$ Million)

Figure 30. Canada Tuberculosis Diagnostics Testing Revenue (2020-2031) & (US$ Million)

Figure 31. Mexico Tuberculosis Diagnostics Testing Revenue (2020-2031) & (US$ Million)

Figure 32. Europe Tuberculosis Diagnostics Testing Revenue YoY (2020-2031) & (US$ Million)

Figure 33. Europe Top 5 Players Tuberculosis Diagnostics Testing Revenue (US$ Million) in 2024

Figure 34. Europe Tuberculosis Diagnostics Testing Revenue (US$ Million) by Type (2020-2031)

Figure 35. Europe Tuberculosis Diagnostics Testing Revenue (US$ Million) by Application (2020-2031)

Figure 36. Germany Tuberculosis Diagnostics Testing Revenue (2020-2031) & (US$ Million)

Figure 37. France Tuberculosis Diagnostics Testing Revenue (2020-2031) & (US$ Million)

Figure 38. U.K. Tuberculosis Diagnostics Testing Revenue (2020-2031) & (US$ Million)

Figure 39. Italy Tuberculosis Diagnostics Testing Revenue (2020-2031) & (US$ Million)

Figure 40. Russia Tuberculosis Diagnostics Testing Revenue (2020-2031) & (US$ Million)

Figure 41. Asia-Pacific Tuberculosis Diagnostics Testing Revenue YoY (2020-2031) & (US$ Million)

Figure 42. Asia-Pacific Top 8 Players Tuberculosis Diagnostics Testing Revenue (US$ Million) in 2024

Figure 43. Asia-Pacific Tuberculosis Diagnostics Testing Revenue (US$ Million) by Type (2020-2031)

Figure 44. Asia-Pacific Tuberculosis Diagnostics Testing Revenue (US$ Million) by Application (2020-2031)

Figure 45. Indonesia Tuberculosis Diagnostics Testing Revenue (2020-2031) & (US$ Million)

Figure 46. Japan Tuberculosis Diagnostics Testing Revenue (2020-2031) & (US$ Million)

Figure 47. South Korea Tuberculosis Diagnostics Testing Revenue (2020-2031) & (US$ Million)

Figure 48. Australia Tuberculosis Diagnostics Testing Revenue (2020-2031) & (US$ Million)

Figure 49. India Tuberculosis Diagnostics Testing Revenue (2020-2031) & (US$ Million)

Figure 50. Indonesia Tuberculosis Diagnostics Testing Revenue (2020-2031) & (US$ Million)

Figure 51. Vietnam Tuberculosis Diagnostics Testing Revenue (2020-2031) & (US$ Million)

Figure 52. Malaysia Tuberculosis Diagnostics Testing Revenue (2020-2031) & (US$ Million)

Figure 53. Philippines Tuberculosis Diagnostics Testing Revenue (2020-2031) & (US$ Million)

Figure 54. Singapore Tuberculosis Diagnostics Testing Revenue (2020-2031) & (US$ Million)

Figure 55. Central and South America Tuberculosis Diagnostics Testing Revenue YoY (2020-2031) & (US$ Million)

Figure 56. Central and South America Top 5 Players Tuberculosis Diagnostics Testing Revenue (US$ Million) in 2024

Figure 57. Central and South America Tuberculosis Diagnostics Testing Revenue (US$ Million) by Type (2020-2031)

Figure 58. Central and South America Tuberculosis Diagnostics Testing Revenue (US$ Million) by Application (2020-2031)

Figure 59. Brazil Tuberculosis Diagnostics Testing Revenue (2020-2025) & (US$ Million)

Figure 60. Argentina Tuberculosis Diagnostics Testing Revenue (2020-2025) & (US$ Million)

Figure 61. Middle East and Africa Tuberculosis Diagnostics Testing Revenue YoY (2020-2031) & (US$ Million)

Figure 62. Middle East and Africa Top 5 Players Tuberculosis Diagnostics Testing Revenue (US$ Million) in 2024

Figure 63. South America Tuberculosis Diagnostics Testing Revenue (US$ Million) by Type (2020-2031)

Figure 64. Middle East and Africa Tuberculosis Diagnostics Testing Revenue (US$ Million) by Application (2020-2031)

Figure 65. GCC Countries Tuberculosis Diagnostics Testing Revenue (2020-2025) & (US$ Million)

Figure 66. Israel Tuberculosis Diagnostics Testing Revenue (2020-2025) & (US$ Million)

Figure 67. Egypt Tuberculosis Diagnostics Testing Revenue (2020-2025) & (US$ Million)

Figure 68. South Africa Tuberculosis Diagnostics Testing Revenue (2020-2025) & (US$ Million)

Figure 69. Tuberculosis Diagnostics Testing Industry Chain Mapping

Figure 70. Channels of Distribution (Direct Vs Distribution)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions